LIECHTENSTEIN
LIECHTENST
FDA import refusal data for products from LIECHTENSTEIN
Common Violations
Top Firms
| # | Firm Name | Risk | Refusals |
|---|---|---|---|
| 1 | Ivoclar Vivadent AG Schaan | Risk: 51.8 | 28 |
| 2 | BEMER INT. AG Triesen | Risk: 50.6 | 14 |
| 3 | EUROLIT EU Vilnius | Risk: 45.5 | 1 |
| 4 | SWISS SANA AG Vaduz | Risk: 24.3 | 1 |
| 5 | Chemical Ag Vaduz | Risk: 24.3 | 1 |
Frequently Asked Questions
How many FDA import refusals are from LIECHTENSTEIN?
According to FDA records, there have been 45 import refusals for products originating from LIECHTENSTEIN, involving 5 firms.
What products from LIECHTENSTEIN are commonly refused by the FDA?
Products from LIECHTENSTEIN may be refused for various reasons including adulteration, misbranding, lack of proper registration, or failure to meet U.S. safety standards. The specific products vary by firm and time period. View the common violations section on this page for more details.
Does an import refusal mean products from LIECHTENSTEIN are unsafe?
Not necessarily. An import refusal indicates a specific shipment appeared to violate FDA requirements at the time of inspection. Many LIECHTENSTEIN firms successfully import products that meet all FDA requirements. Import refusals help identify and prevent non-compliant products from entering the U.S. market.
How current is the FDA import refusal data for LIECHTENSTEIN?
Our database includes FDA import refusals for LIECHTENSTEIN through 8/21/2025. Data is sourced from the FDA Data Dashboard and updated monthly.
Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.